Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Elagolix did not effectively treat polycystic ovary syndrome.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

GPR40 agonists help hair growth through the protein ANGPTL4.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Licorice can effectively treat stomach ulcers and may work as well as or better than some standard drugs.

GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.